BMO Capital analyst Joel Jackson raised the firm’s price target on Corteva (CTVA) to $86 from $74 and keeps an Outperform rating on the shares. The stock can continue to work as its current attractive multiples keep getting rolled forward on a strong growth profile, the analyst tells investors in a research note. BMO adds that Corteva is among the best-in-class among agricultural/fertilizer stocks for compelling multi-year double-digit EBITDA CAGR and margin expansion.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva’s Strong Growth Potential and Financial Resilience Earns Buy Rating with Raised Target Price
- Corteva price target raised to $75 from $70 at Barclays
- Corteva price target raised to $82 from $79 at Wells Fargo
- Food, agriculture leaders warn of MAHA’s overreach, WSJ reports
- Corteva, Micropep partner on sustainable biocontrol solutions